Sandy Spring Bank’s Flexion Therapeutics, Inc. FLXN Stock Holding History

Sandy Spring Bank’s Portfolio FLXN Stock Details FLXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-900	Closed	-$5K	–	1274
2021 Q3	$5K	Hold	900	–	–	﹤0.01%	987
2021 Q2	$7K	Hold	900	–	–	﹤0.01%	951
2021 Q1	$8K	Hold	900	–	–	﹤0.01%	834
2020 Q4	$10K	Hold	900	–	–	﹤0.01%	757
2020 Q3	$9K	Hold	900	–	–	﹤0.01%	698
2020 Q2	$12K	Hold	900	–	–	﹤0.01%	676
2020 Q1	$7K	Hold	900	–	–	﹤0.01%	724
2019 Q4	$19K	Hold	900	–	–	﹤0.01%	630
2019 Q3	$12K	Hold	900	–	–	﹤0.01%	704
2019 Q2	$11K	Hold	900	–	–	﹤0.01%	705
2019 Q1	$11K	Hold	900	–	–	﹤0.01%	668
2018 Q4	$10K	Hold	900	–	–	﹤0.01%	668
2018 Q3	$17K	Hold	900	–	–	﹤0.01%	618
2018 Q2	$23K	Hold	900	–	–	﹤0.01%	568
2018 Q1	$20K	Buy	+900	New	+$22K	﹤0.01%	606

Sandy Spring Bank's FLXN Position: Q4 2021 in Review

Sandy Spring Bank sold out of Flexion Therapeutics, Inc. (FLXN) in Q4 2021, closing a stake of 900 shares — an estimated $5K sold.

Sandy Spring Bank first reported a position in FLXN in Q1 2018 and held it in 15 quarters. The position peaked at $23K in Q2 2018. 1 fund tracked by Wall St. Rank holds FLXN as of Q4 2021.

Sandy Spring Bank reported no remaining Flexion Therapeutics, Inc. position as of Q4 2021 after selling out during the quarter.
Sandy Spring Bank sold 900 Flexion Therapeutics, Inc. shares in Q4 2021, an estimated $5K.
Sandy Spring Bank first reported a position in Flexion Therapeutics, Inc. in Q1 2018 and held it in 15 quarters.
Sandy Spring Bank's Flexion Therapeutics, Inc. position peaked at $23K in Q2 2018.
1 fund tracked by Wall St. Rank held Flexion Therapeutics, Inc. as of Q4 2021.

Based on Sandy Spring Bank's 13F filing for Q4 2021, filed 11 Feb 2022.